Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.270
-0.030 (-2.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Akso Health Group Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -18.67 | -134.98 | -9.46 | -1.36 | -16.85 |
Depreciation & Amortization | 2.37 | 2.15 | - | - | - |
Asset Writedown & Restructuring Costs | 16.7 | 162.48 | - | - | - |
Stock-Based Compensation | - | - | - | - | 0.39 |
Provision & Write-off of Bad Debts | 0.11 | -0.1 | 7.37 | 8.27 | - |
Other Operating Activities | -1.95 | -31.39 | 0.74 | -11.72 | 12.75 |
Change in Accounts Receivable | -0.44 | -0.86 | 0.33 | -8.1 | - |
Change in Inventory | - | - | 1.5 | 6.11 | -7.8 |
Change in Accounts Payable | 0.31 | 0.42 | 0.17 | 0.71 | 0.15 |
Change in Unearned Revenue | -5.81 | 9.86 | 0.22 | 0.19 | - |
Change in Income Taxes | 0.06 | -0.04 | -0.02 | 0 | 0.09 |
Change in Other Net Operating Assets | -5.48 | -6.36 | -0.13 | -0.1 | -0.02 |
Operating Cash Flow | -12.79 | 1.18 | 1.35 | -3.25 | -8.63 |
Operating Cash Flow Growth | - | -12.88% | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0 | -0.15 | - | - | - |
Cash Acquisitions | - | -93.75 | -56.25 | - | - |
Sale (Purchase) of Intangibles | -175.66 | - | - | - | - |
Other Investing Activities | - | - | - | - | 0.04 |
Investing Cash Flow | -163.46 | -105.91 | -54.72 | 18.47 | -19.96 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 0.35 | - | - | - | 9.09 |
Total Debt Issued | 0.35 | - | - | - | 9.09 |
Short-Term Debt Repaid | - | - | -7.69 | -27.51 | - |
Long-Term Debt Repaid | - | - | - | - | -10 |
Total Debt Repaid | - | - | -7.69 | -27.51 | -10 |
Net Debt Issued (Repaid) | 0.35 | - | -7.69 | -27.51 | -0.91 |
Issuance of Common Stock | - | 195.88 | 139.34 | - | 10.02 |
Other Financing Activities | - | - | - | - | 25.68 |
Financing Cash Flow | 0.35 | 195.88 | 131.65 | -27.51 | 34.78 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | -0.15 | -1.12 | -1.27 | -0.44 | 0.61 |
Net Cash Flow | -176.06 | 90.03 | 77.01 | -12.73 | 6.8 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -12.79 | 1.02 | 1.35 | -3.25 | -8.63 |
Free Cash Flow Growth | - | -24.31% | - | - | - |
Free Cash Flow Margin | -92.49% | 6.92% | 55.97% | -24.68% | -143.81% |
Free Cash Flow Per Share | -0.02 | 0.00 | 0.03 | -0.14 | -0.43 |
Levered Free Cash Flow | -350.71 | 46.67 | -50.05 | 11.54 | -19.15 |
Unlevered Free Cash Flow | -350.71 | 46.67 | -50.05 | 11.54 | -18.65 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | - | 0.11 | 0.34 | 0.68 |
Cash Income Tax Paid | 0 | 0 | 0.02 | 0.02 | 0.09 |
Change in Working Capital | -11.35 | 3.02 | 2.06 | -1.17 | -7.57 |